Not sure that for patients waiting around for an hour with the current testing regime is a big deal. I have done it twice and would prefer to having to return to the testing centre the next day. I thought a potentially significant advantage of CU6's technology is that it remains effective significantly longer so a more centralised manufacturing and distribution model is possible as compared with, say Telix's product.
- Forums
- ASX - By Stock
- Ann: First patient treated in theranostic prostate cancer trial
Not sure that for patients waiting around for an hour with the...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
|
|||||
Last
$7.24 |
Change
-0.050(0.69%) |
Mkt cap ! $2.286B |
Open | High | Low | Value | Volume |
$7.25 | $7.35 | $7.18 | $1.650M | 227.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 1620 | $7.24 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$7.25 | 8 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 524 | 7.240 |
2 | 447 | 7.230 |
5 | 1990 | 7.220 |
2 | 1200 | 7.210 |
5 | 3962 | 7.200 |
Price($) | Vol. | No. |
---|---|---|
7.250 | 540 | 7 |
7.260 | 1825 | 6 |
7.270 | 2324 | 4 |
7.280 | 2312 | 3 |
7.290 | 5383 | 5 |
Last trade - 11.30am 03/09/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |